“We are pleased to report 217.5% revenue growth, Adjusted EBITDA attributable to Nutex Health (NUTX) of $144.4 million, a 643.5% increase in gross profit and a record high cash balance of $96.7 million, highlighting the company’s continued financial strength and solid fundamentals as we execute on our growth plan for 2025,” stated Jon Bates, Chief Financial Officer of Nutex Health.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUTX: